Search for:
Avacta Life Sciences Limited
About
Therapeutics
Diagnostics
Investors
News
Careers
Contact
About
About Avacta
People
Scientific Resources
Intellectual Property
Virtual tour
Therapeutics
Therapeutics
Affimer
®
pre
CISION
TM
Pipeline
Partnering
Clinical trials
News
Diagnostics
Diagnostics
Products
Affimer
®
Key benefits
Partnering
Resources
News
Investors
Investors
CEO Welcome
Key information
Corporate Governance
Documents & Presentations
Share price
RNS News
News
Careers
CEO Welcome
Job vacancies
About Avacta
Benefits of working at Avacta
Contact
About
About Avacta
People
Scientific Resources
Intellectual Property
Virtual tour
Therapeutics
Therapeutics
Affimer
®
pre
CISION
TM
Pipeline
Partnering
Clinical trials
News
Diagnostics
Diagnostics
Products
Affimer
®
Key benefits
Partnering
Resources
News
Investors
Investors
CEO Welcome
Key information
Corporate Governance
Documents & Presentations
Share price
RNS News
News
Careers
CEO Welcome
Job vacancies
About Avacta
Benefits of working at Avacta
Contact
Home
News
Investors
filter by:
view all
|
Blogs
|
Diagnostics
|
Investors
|
Therapeutics
Investors
08 Nov 2022
Director/PDMR Shareholding
Investors
08 Nov 2022
Result of the Open Offer
Investors
31 Oct 2022
Avacta to Present at Virtual Theranostics FAP Summit
Investors
|
Therapeutics
28 Oct 2022
Block Listing Six Monthly Return
Investors
20 Oct 2022
Director/PDMR Shareholding
Investors
20 Oct 2022
Admission of the Company’s Ordinary Shares
Investors
20 Oct 2022
Posting of the Company’s Open Offer Circular
Investors
18 Oct 2022
Result of placing
Investors
18 Oct 2022
Proposed placing, open offer and issue of convertible bonds
Diagnostics
|
Investors
18 Oct 2022
Proposed acquisition of Launch Diagnostics
Diagnostics
|
Investors
Posts navigation
Older posts
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok